Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Recent advances in antiretroviral therapy and HIV infection monitoring
Jean Claude Schmit
, Bernard Weber
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
25
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recent advances in antiretroviral therapy and HIV infection monitoring'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Recent Advances
100%
HIV Infection
100%
Antiretroviral Therapy
100%
Infection Surveillance
100%
Protease Inhibitors
33%
Antiviral Drugs
33%
Antiretroviral Activity
33%
Clinical Trials
16%
Disease Progression
16%
Viral Load
16%
Treatment Strategy
16%
Disease Stage
16%
Clinical Outcomes
16%
Advanced Stage
16%
Protease
16%
Reverse Transcriptase
16%
Highly Active Antiretroviral Therapy (HAART)
16%
HIV Patients
16%
Combination Regimen
16%
Limit of Detection
16%
Cross-resistance
16%
Treatment Regimen
16%
HIV-1 Replication
16%
Rapid Progress
16%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
16%
Nucleoside Reverse Transcriptase Inhibitors
16%
Treatment-naïve
16%
Naïve Patients
16%
Resistant Virus
16%
Abacavir
16%
Resistance Pattern
16%
New Antiretrovirals
16%
Adefovir Dipivoxil
16%
HIV Pathogenesis
16%
Resistance Evaluation
16%
Double Combination
16%
Active Pharmaceutical Ingredients
16%
Nucleic Acid Amplification
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Human Immunodeficiency Virus Infection
100%
RNA Directed DNA Polymerase Inhibitor
33%
Proteinase Inhibitor
33%
Clinical Trial
16%
Nonnucleoside Reverse Transcriptase Inhibitor
16%
Virus
16%
Nucleic Acid
16%
Proteinase
16%
Disease Exacerbation
16%
Cross-Resistance
16%
Abacavir
16%
Diseases
16%
Pathogenesis
16%
Reverse Transcriptase
16%